Drastically Increased Expression of MYC and FOS Protooncogenes during in vitro Differentiation of Chronic Lymphocytic Leukemia Cells
Chronic lymphocytic leukemia cells, representing a clonal population of resting B lymphocytes, were induced to differentiate into immunoglobulin-secreting lymphoblasts and plasmablasts by phorbol 12-myristate 13-acetate. The induction resulted in a rapid increase in the molar ratio of secreted/membr...
Gespeichert in:
Veröffentlicht in: | Proc. Natl. Acad. Sci. U.S.A.; (United States) 1987-01, Vol.84 (1), p.223-227 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 227 |
---|---|
container_issue | 1 |
container_start_page | 223 |
container_title | Proc. Natl. Acad. Sci. U.S.A.; (United States) |
container_volume | 84 |
creator | Larsson, Lars-Gunnar Gray, Harry E. Tötterman, Thomas Pettersson, Ulf Nilsson, Kenneth |
description | Chronic lymphocytic leukemia cells, representing a clonal population of resting B lymphocytes, were induced to differentiate into immunoglobulin-secreting lymphoblasts and plasmablasts by phorbol 12-myristate 13-acetate. The induction resulted in a rapid increase in the molar ratio of secreted/membrane-bound μ -chain mRNA. Immunoglobulin secretion was preceded by a transition of the cells from the G0 to G1 phase of the cell cycle, as indicated by an increase in RNA and protein synthesis, and an overall increase in cellular RNA. The cells, however, became blocked in G1 and did not enter S phase. The expression of MYC and FOS was rapidly induced by the phorbol 12-myristate 13-acetate treatment. The induction of FOS preceded the shift in secreted/membrane-bound μ -chain mRNA molar ratio, while that of MYC occurred concomitantly with the shift, but prior to induction of total RNA synthesis and immunoglobulin secretion. MYC expression remained at a relatively high level during the whole differentiation process. It is thus concluded that a decline of MYC expression is not a prerequisite for differentiation of the chronic lymphocytic leukemia cells. This suggests that MYC expression may play a different role during differentiation of nonproliferating B cells than in the myelomonocytic cell lines HL-60 and U-937, where MYC expression has been reported to decrease during induced differentiation. The results also show that the expression of the MYC and FOS genes does not result in the transition of these cells into the S phase of the cell cycle. |
doi_str_mv | 10.1073/pnas.84.1.223 |
format | Article |
fullrecord | <record><control><sourceid>jstor_osti_</sourceid><recordid>TN_cdi_jstor_primary_28981</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>28981</jstor_id><sourcerecordid>28981</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4243-76e8b2d10bf207ed16737803e80bd24af21f635903e2d06e88dea00959d25e0c3</originalsourceid><addsrcrecordid>eNp9kUtv1DAUhS0EKkNhyQaBZCHBLoMfeTgLFihtodKgIgELVpbHuZlxydip7VSdPT8chwmjsmFly-c79-GD0HNKlpRU_N1gVViKfEmXjPEHaEFJTbMyr8lDtCCEVZnIWf4YPQnhmhBSF4KcoBNO6prVfIF-nXkVotGq7_f40moPKkCLz-8GDyEYZ7Hr8OcfDVa2xRdXX_EX76JzVrsNWAi4Hb2xG2wsvjXRO3xmug482GhUnN3N1jtrNF7td8PW6X2c7jD-hJ1RuIG-D0_Ro071AZ7N5yn6fnH-rfmUra4-XjYfVplOK_CsKkGsWUvJumOkgpaWFa8E4SDIumW56hjtSl7U6YW1JMGiBTWtXLesAKL5KXp_qDuM6x20Oo3pVS8Hb3bK76VTRv6rWLOVG3crOclpVST_64PfpS-TQZsIequdtaCjLEpSVIIl6O3cxLubEUKUOxN0WlNZcGOQNK8oq_5Uyw6g9i4ED91xEErkFK2copUil1SmaBP_6v70R3rOMukvZ32y_VXv2d_8R5bd2PcR7mLiXhy46xCdP4JM1ILy30ePwc0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>14712775</pqid></control><display><type>article</type><title>Drastically Increased Expression of MYC and FOS Protooncogenes during in vitro Differentiation of Chronic Lymphocytic Leukemia Cells</title><source>Jstor Complete Legacy</source><source>MEDLINE</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><creator>Larsson, Lars-Gunnar ; Gray, Harry E. ; Tötterman, Thomas ; Pettersson, Ulf ; Nilsson, Kenneth</creator><creatorcontrib>Larsson, Lars-Gunnar ; Gray, Harry E. ; Tötterman, Thomas ; Pettersson, Ulf ; Nilsson, Kenneth ; University Hospital, Uppsala, Sweden</creatorcontrib><description>Chronic lymphocytic leukemia cells, representing a clonal population of resting B lymphocytes, were induced to differentiate into immunoglobulin-secreting lymphoblasts and plasmablasts by phorbol 12-myristate 13-acetate. The induction resulted in a rapid increase in the molar ratio of secreted/membrane-bound μ -chain mRNA. Immunoglobulin secretion was preceded by a transition of the cells from the G0 to G1 phase of the cell cycle, as indicated by an increase in RNA and protein synthesis, and an overall increase in cellular RNA. The cells, however, became blocked in G1 and did not enter S phase. The expression of MYC and FOS was rapidly induced by the phorbol 12-myristate 13-acetate treatment. The induction of FOS preceded the shift in secreted/membrane-bound μ -chain mRNA molar ratio, while that of MYC occurred concomitantly with the shift, but prior to induction of total RNA synthesis and immunoglobulin secretion. MYC expression remained at a relatively high level during the whole differentiation process. It is thus concluded that a decline of MYC expression is not a prerequisite for differentiation of the chronic lymphocytic leukemia cells. This suggests that MYC expression may play a different role during differentiation of nonproliferating B cells than in the myelomonocytic cell lines HL-60 and U-937, where MYC expression has been reported to decrease during induced differentiation. The results also show that the expression of the MYC and FOS genes does not result in the transition of these cells into the S phase of the cell cycle.</description><identifier>ISSN: 0027-8424</identifier><identifier>EISSN: 1091-6490</identifier><identifier>DOI: 10.1073/pnas.84.1.223</identifier><identifier>PMID: 3099293</identifier><language>eng</language><publisher>United States: National Academy of Sciences of the United States of America</publisher><subject>550601 - Medicine- Unsealed Radionuclides in Diagnostics ; 560300 - Chemicals Metabolism & Toxicology ; Actins - genetics ; ANIMAL CELLS ; AZINES ; B cell leukemia ; B lymphocytes ; BIOLOGICAL EFFECTS ; CARCINOGENS ; CELL DIFFERENTIATION ; Cell Differentiation - drug effects ; Cell growth ; Cell Line ; Cell lines ; Cellular differentiation ; Cellular immunity ; DISEASES ; DNA Replication ; ESTERS ; GENE REGULATION ; GENES ; GLOBULINS ; HEMIC DISEASES ; HETEROCYCLIC COMPOUNDS ; Humans ; HYDROXY COMPOUNDS ; IMMUNOASSAY ; Immunoglobulin M - analysis ; Immunoglobulin mu-Chains - genetics ; IMMUNOGLOBULINS ; IMMUNOLOGY ; ISOTOPE APPLICATIONS ; LABELLED COMPOUNDS ; LEUKEMIA ; Leukemia, Lymphoid - genetics ; Leukemia, Lymphoid - immunology ; Leukemia, Lymphoid - pathology ; Lymphocytes - immunology ; Messenger RNA ; NEOPLASMS ; NUCLEOSIDES ; NUCLEOTIDES ; ONCOGENES ; ORGANIC COMPOUNDS ; ORGANIC NITROGEN COMPOUNDS ; PHORBOL ESTERS ; Plasma cells ; PROTEINS ; Proto-Oncogenes ; PYRIMIDINES ; RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT ; RADIOASSAY ; RADIOIMMUNOASSAY ; RADIOIMMUNOLOGY ; RADIOLOGY AND NUCLEAR MEDICINE ; RIBOSIDES ; RNA ; RNA, Messenger - genetics ; T lymphocytes ; Tetradecanoylphorbol Acetate - pharmacology ; THYMIDINE ; TRACER TECHNIQUES ; Transcription, Genetic ; TRITIUM COMPOUNDS ; TUMOR CELLS ; URACILS ; URIDINE</subject><ispartof>Proc. Natl. Acad. Sci. U.S.A.; (United States), 1987-01, Vol.84 (1), p.223-227</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4243-76e8b2d10bf207ed16737803e80bd24af21f635903e2d06e88dea00959d25e0c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://www.pnas.org/content/84/1.cover.gif</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/28981$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/28981$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,723,776,780,799,881,27901,27902,53766,53768,57992,58225</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3099293$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/biblio/5605782$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>Larsson, Lars-Gunnar</creatorcontrib><creatorcontrib>Gray, Harry E.</creatorcontrib><creatorcontrib>Tötterman, Thomas</creatorcontrib><creatorcontrib>Pettersson, Ulf</creatorcontrib><creatorcontrib>Nilsson, Kenneth</creatorcontrib><creatorcontrib>University Hospital, Uppsala, Sweden</creatorcontrib><title>Drastically Increased Expression of MYC and FOS Protooncogenes during in vitro Differentiation of Chronic Lymphocytic Leukemia Cells</title><title>Proc. Natl. Acad. Sci. U.S.A.; (United States)</title><addtitle>Proc Natl Acad Sci U S A</addtitle><description>Chronic lymphocytic leukemia cells, representing a clonal population of resting B lymphocytes, were induced to differentiate into immunoglobulin-secreting lymphoblasts and plasmablasts by phorbol 12-myristate 13-acetate. The induction resulted in a rapid increase in the molar ratio of secreted/membrane-bound μ -chain mRNA. Immunoglobulin secretion was preceded by a transition of the cells from the G0 to G1 phase of the cell cycle, as indicated by an increase in RNA and protein synthesis, and an overall increase in cellular RNA. The cells, however, became blocked in G1 and did not enter S phase. The expression of MYC and FOS was rapidly induced by the phorbol 12-myristate 13-acetate treatment. The induction of FOS preceded the shift in secreted/membrane-bound μ -chain mRNA molar ratio, while that of MYC occurred concomitantly with the shift, but prior to induction of total RNA synthesis and immunoglobulin secretion. MYC expression remained at a relatively high level during the whole differentiation process. It is thus concluded that a decline of MYC expression is not a prerequisite for differentiation of the chronic lymphocytic leukemia cells. This suggests that MYC expression may play a different role during differentiation of nonproliferating B cells than in the myelomonocytic cell lines HL-60 and U-937, where MYC expression has been reported to decrease during induced differentiation. The results also show that the expression of the MYC and FOS genes does not result in the transition of these cells into the S phase of the cell cycle.</description><subject>550601 - Medicine- Unsealed Radionuclides in Diagnostics</subject><subject>560300 - Chemicals Metabolism & Toxicology</subject><subject>Actins - genetics</subject><subject>ANIMAL CELLS</subject><subject>AZINES</subject><subject>B cell leukemia</subject><subject>B lymphocytes</subject><subject>BIOLOGICAL EFFECTS</subject><subject>CARCINOGENS</subject><subject>CELL DIFFERENTIATION</subject><subject>Cell Differentiation - drug effects</subject><subject>Cell growth</subject><subject>Cell Line</subject><subject>Cell lines</subject><subject>Cellular differentiation</subject><subject>Cellular immunity</subject><subject>DISEASES</subject><subject>DNA Replication</subject><subject>ESTERS</subject><subject>GENE REGULATION</subject><subject>GENES</subject><subject>GLOBULINS</subject><subject>HEMIC DISEASES</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>Humans</subject><subject>HYDROXY COMPOUNDS</subject><subject>IMMUNOASSAY</subject><subject>Immunoglobulin M - analysis</subject><subject>Immunoglobulin mu-Chains - genetics</subject><subject>IMMUNOGLOBULINS</subject><subject>IMMUNOLOGY</subject><subject>ISOTOPE APPLICATIONS</subject><subject>LABELLED COMPOUNDS</subject><subject>LEUKEMIA</subject><subject>Leukemia, Lymphoid - genetics</subject><subject>Leukemia, Lymphoid - immunology</subject><subject>Leukemia, Lymphoid - pathology</subject><subject>Lymphocytes - immunology</subject><subject>Messenger RNA</subject><subject>NEOPLASMS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ONCOGENES</subject><subject>ORGANIC COMPOUNDS</subject><subject>ORGANIC NITROGEN COMPOUNDS</subject><subject>PHORBOL ESTERS</subject><subject>Plasma cells</subject><subject>PROTEINS</subject><subject>Proto-Oncogenes</subject><subject>PYRIMIDINES</subject><subject>RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT</subject><subject>RADIOASSAY</subject><subject>RADIOIMMUNOASSAY</subject><subject>RADIOIMMUNOLOGY</subject><subject>RADIOLOGY AND NUCLEAR MEDICINE</subject><subject>RIBOSIDES</subject><subject>RNA</subject><subject>RNA, Messenger - genetics</subject><subject>T lymphocytes</subject><subject>Tetradecanoylphorbol Acetate - pharmacology</subject><subject>THYMIDINE</subject><subject>TRACER TECHNIQUES</subject><subject>Transcription, Genetic</subject><subject>TRITIUM COMPOUNDS</subject><subject>TUMOR CELLS</subject><subject>URACILS</subject><subject>URIDINE</subject><issn>0027-8424</issn><issn>1091-6490</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1987</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUtv1DAUhS0EKkNhyQaBZCHBLoMfeTgLFihtodKgIgELVpbHuZlxydip7VSdPT8chwmjsmFly-c79-GD0HNKlpRU_N1gVViKfEmXjPEHaEFJTbMyr8lDtCCEVZnIWf4YPQnhmhBSF4KcoBNO6prVfIF-nXkVotGq7_f40moPKkCLz-8GDyEYZ7Hr8OcfDVa2xRdXX_EX76JzVrsNWAi4Hb2xG2wsvjXRO3xmug482GhUnN3N1jtrNF7td8PW6X2c7jD-hJ1RuIG-D0_Ro071AZ7N5yn6fnH-rfmUra4-XjYfVplOK_CsKkGsWUvJumOkgpaWFa8E4SDIumW56hjtSl7U6YW1JMGiBTWtXLesAKL5KXp_qDuM6x20Oo3pVS8Hb3bK76VTRv6rWLOVG3crOclpVST_64PfpS-TQZsIequdtaCjLEpSVIIl6O3cxLubEUKUOxN0WlNZcGOQNK8oq_5Uyw6g9i4ED91xEErkFK2copUil1SmaBP_6v70R3rOMukvZ32y_VXv2d_8R5bd2PcR7mLiXhy46xCdP4JM1ILy30ePwc0</recordid><startdate>19870101</startdate><enddate>19870101</enddate><creator>Larsson, Lars-Gunnar</creator><creator>Gray, Harry E.</creator><creator>Tötterman, Thomas</creator><creator>Pettersson, Ulf</creator><creator>Nilsson, Kenneth</creator><general>National Academy of Sciences of the United States of America</general><general>National Acad Sciences</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>RC3</scope><scope>OTOTI</scope><scope>5PM</scope></search><sort><creationdate>19870101</creationdate><title>Drastically Increased Expression of MYC and FOS Protooncogenes during in vitro Differentiation of Chronic Lymphocytic Leukemia Cells</title><author>Larsson, Lars-Gunnar ; Gray, Harry E. ; Tötterman, Thomas ; Pettersson, Ulf ; Nilsson, Kenneth</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4243-76e8b2d10bf207ed16737803e80bd24af21f635903e2d06e88dea00959d25e0c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1987</creationdate><topic>550601 - Medicine- Unsealed Radionuclides in Diagnostics</topic><topic>560300 - Chemicals Metabolism & Toxicology</topic><topic>Actins - genetics</topic><topic>ANIMAL CELLS</topic><topic>AZINES</topic><topic>B cell leukemia</topic><topic>B lymphocytes</topic><topic>BIOLOGICAL EFFECTS</topic><topic>CARCINOGENS</topic><topic>CELL DIFFERENTIATION</topic><topic>Cell Differentiation - drug effects</topic><topic>Cell growth</topic><topic>Cell Line</topic><topic>Cell lines</topic><topic>Cellular differentiation</topic><topic>Cellular immunity</topic><topic>DISEASES</topic><topic>DNA Replication</topic><topic>ESTERS</topic><topic>GENE REGULATION</topic><topic>GENES</topic><topic>GLOBULINS</topic><topic>HEMIC DISEASES</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>Humans</topic><topic>HYDROXY COMPOUNDS</topic><topic>IMMUNOASSAY</topic><topic>Immunoglobulin M - analysis</topic><topic>Immunoglobulin mu-Chains - genetics</topic><topic>IMMUNOGLOBULINS</topic><topic>IMMUNOLOGY</topic><topic>ISOTOPE APPLICATIONS</topic><topic>LABELLED COMPOUNDS</topic><topic>LEUKEMIA</topic><topic>Leukemia, Lymphoid - genetics</topic><topic>Leukemia, Lymphoid - immunology</topic><topic>Leukemia, Lymphoid - pathology</topic><topic>Lymphocytes - immunology</topic><topic>Messenger RNA</topic><topic>NEOPLASMS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ONCOGENES</topic><topic>ORGANIC COMPOUNDS</topic><topic>ORGANIC NITROGEN COMPOUNDS</topic><topic>PHORBOL ESTERS</topic><topic>Plasma cells</topic><topic>PROTEINS</topic><topic>Proto-Oncogenes</topic><topic>PYRIMIDINES</topic><topic>RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT</topic><topic>RADIOASSAY</topic><topic>RADIOIMMUNOASSAY</topic><topic>RADIOIMMUNOLOGY</topic><topic>RADIOLOGY AND NUCLEAR MEDICINE</topic><topic>RIBOSIDES</topic><topic>RNA</topic><topic>RNA, Messenger - genetics</topic><topic>T lymphocytes</topic><topic>Tetradecanoylphorbol Acetate - pharmacology</topic><topic>THYMIDINE</topic><topic>TRACER TECHNIQUES</topic><topic>Transcription, Genetic</topic><topic>TRITIUM COMPOUNDS</topic><topic>TUMOR CELLS</topic><topic>URACILS</topic><topic>URIDINE</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Larsson, Lars-Gunnar</creatorcontrib><creatorcontrib>Gray, Harry E.</creatorcontrib><creatorcontrib>Tötterman, Thomas</creatorcontrib><creatorcontrib>Pettersson, Ulf</creatorcontrib><creatorcontrib>Nilsson, Kenneth</creatorcontrib><creatorcontrib>University Hospital, Uppsala, Sweden</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>OSTI.GOV</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Proc. Natl. Acad. Sci. U.S.A.; (United States)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Larsson, Lars-Gunnar</au><au>Gray, Harry E.</au><au>Tötterman, Thomas</au><au>Pettersson, Ulf</au><au>Nilsson, Kenneth</au><aucorp>University Hospital, Uppsala, Sweden</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Drastically Increased Expression of MYC and FOS Protooncogenes during in vitro Differentiation of Chronic Lymphocytic Leukemia Cells</atitle><jtitle>Proc. Natl. Acad. Sci. U.S.A.; (United States)</jtitle><addtitle>Proc Natl Acad Sci U S A</addtitle><date>1987-01-01</date><risdate>1987</risdate><volume>84</volume><issue>1</issue><spage>223</spage><epage>227</epage><pages>223-227</pages><issn>0027-8424</issn><eissn>1091-6490</eissn><abstract>Chronic lymphocytic leukemia cells, representing a clonal population of resting B lymphocytes, were induced to differentiate into immunoglobulin-secreting lymphoblasts and plasmablasts by phorbol 12-myristate 13-acetate. The induction resulted in a rapid increase in the molar ratio of secreted/membrane-bound μ -chain mRNA. Immunoglobulin secretion was preceded by a transition of the cells from the G0 to G1 phase of the cell cycle, as indicated by an increase in RNA and protein synthesis, and an overall increase in cellular RNA. The cells, however, became blocked in G1 and did not enter S phase. The expression of MYC and FOS was rapidly induced by the phorbol 12-myristate 13-acetate treatment. The induction of FOS preceded the shift in secreted/membrane-bound μ -chain mRNA molar ratio, while that of MYC occurred concomitantly with the shift, but prior to induction of total RNA synthesis and immunoglobulin secretion. MYC expression remained at a relatively high level during the whole differentiation process. It is thus concluded that a decline of MYC expression is not a prerequisite for differentiation of the chronic lymphocytic leukemia cells. This suggests that MYC expression may play a different role during differentiation of nonproliferating B cells than in the myelomonocytic cell lines HL-60 and U-937, where MYC expression has been reported to decrease during induced differentiation. The results also show that the expression of the MYC and FOS genes does not result in the transition of these cells into the S phase of the cell cycle.</abstract><cop>United States</cop><pub>National Academy of Sciences of the United States of America</pub><pmid>3099293</pmid><doi>10.1073/pnas.84.1.223</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0027-8424 |
ispartof | Proc. Natl. Acad. Sci. U.S.A.; (United States), 1987-01, Vol.84 (1), p.223-227 |
issn | 0027-8424 1091-6490 |
language | eng |
recordid | cdi_jstor_primary_28981 |
source | Jstor Complete Legacy; MEDLINE; PubMed Central; Alma/SFX Local Collection; Free Full-Text Journals in Chemistry |
subjects | 550601 - Medicine- Unsealed Radionuclides in Diagnostics 560300 - Chemicals Metabolism & Toxicology Actins - genetics ANIMAL CELLS AZINES B cell leukemia B lymphocytes BIOLOGICAL EFFECTS CARCINOGENS CELL DIFFERENTIATION Cell Differentiation - drug effects Cell growth Cell Line Cell lines Cellular differentiation Cellular immunity DISEASES DNA Replication ESTERS GENE REGULATION GENES GLOBULINS HEMIC DISEASES HETEROCYCLIC COMPOUNDS Humans HYDROXY COMPOUNDS IMMUNOASSAY Immunoglobulin M - analysis Immunoglobulin mu-Chains - genetics IMMUNOGLOBULINS IMMUNOLOGY ISOTOPE APPLICATIONS LABELLED COMPOUNDS LEUKEMIA Leukemia, Lymphoid - genetics Leukemia, Lymphoid - immunology Leukemia, Lymphoid - pathology Lymphocytes - immunology Messenger RNA NEOPLASMS NUCLEOSIDES NUCLEOTIDES ONCOGENES ORGANIC COMPOUNDS ORGANIC NITROGEN COMPOUNDS PHORBOL ESTERS Plasma cells PROTEINS Proto-Oncogenes PYRIMIDINES RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT RADIOASSAY RADIOIMMUNOASSAY RADIOIMMUNOLOGY RADIOLOGY AND NUCLEAR MEDICINE RIBOSIDES RNA RNA, Messenger - genetics T lymphocytes Tetradecanoylphorbol Acetate - pharmacology THYMIDINE TRACER TECHNIQUES Transcription, Genetic TRITIUM COMPOUNDS TUMOR CELLS URACILS URIDINE |
title | Drastically Increased Expression of MYC and FOS Protooncogenes during in vitro Differentiation of Chronic Lymphocytic Leukemia Cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T02%3A50%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_osti_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Drastically%20Increased%20Expression%20of%20MYC%20and%20FOS%20Protooncogenes%20during%20in%20vitro%20Differentiation%20of%20Chronic%20Lymphocytic%20Leukemia%20Cells&rft.jtitle=Proc.%20Natl.%20Acad.%20Sci.%20U.S.A.;%20(United%20States)&rft.au=Larsson,%20Lars-Gunnar&rft.aucorp=University%20Hospital,%20Uppsala,%20Sweden&rft.date=1987-01-01&rft.volume=84&rft.issue=1&rft.spage=223&rft.epage=227&rft.pages=223-227&rft.issn=0027-8424&rft.eissn=1091-6490&rft_id=info:doi/10.1073/pnas.84.1.223&rft_dat=%3Cjstor_osti_%3E28981%3C/jstor_osti_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=14712775&rft_id=info:pmid/3099293&rft_jstor_id=28981&rfr_iscdi=true |